Financhill
Sell
22

XRAY Quote, Financials, Valuation and Earnings

Last price:
$15.96
Seasonality move :
0.64%
Day range:
$15.87 - $16.51
52-week range:
$12.16 - $28.25
Dividend yield:
4.01%
P/E ratio:
--
P/S ratio:
0.86x
P/B ratio:
1.58x
Volume:
3.8M
Avg. volume:
3.1M
1-year change:
-42.41%
Market cap:
$3.2B
Revenue:
$3.8B
EPS (TTM):
-$4.54

Earnings Data

Next earnings date for XRAY
Jul 31
2025
Most recent earnings per share
$0.10
Missed by $0.20
(May 8/2025)
Consensus Estimate
$0.30
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

XRAY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/31/2025 Q2 $927.2M -- -- $0.49 --
05/08/2025 Q1 $854.2M $879M $0.10 $0.30 -$0.20
02/27/2025 Q4 $920.3M $905M -$2.16 $0.43 -$2.59
11/07/2024 Q3 $939.9M $951M -$2.46 $0.48 -$2.94
07/31/2024 Q2 $993.4M $984M -$0.02 $0.49 -$0.51
05/02/2024 Q1 $968.8M $953M $0.09 $0.42 -$0.33
02/29/2024 Q4 $973.3M $1B $0.32 $0.44 -$0.12
11/02/2023 Q3 -- -- -$1.25 $0.48 -$1.73
08/03/2023 Q2 -- -- $0.40 $0.43 -$0.03
05/03/2023 Q1 -- -- -$0.09 $0.34 -$0.43
02/28/2023 Q4 -- -- -$0.07 $0.32 -$0.39
11/14/2022 Q3 -- -- -$5.01 $0.58 -$5.59
09/27/2022 Q2 -- -- $0.34 $0.57 -$0.23
05/05/2022 Q1 -- -- $0.32 $0.55 -$0.23
02/28/2022 Q4 -- -- $0.47 $0.79 -$0.32
11/04/2021 Q3 -- -- $0.47 $0.65 -$0.18
08/05/2021 Q2 -- -- $0.45 $0.66 -$0.21
05/06/2021 Q1 -- -- $0.53 $0.56 -$0.03
03/01/2021 Q4 -- -- $0.45 $0.64 -$0.19
11/05/2020 Q3 -- -- $0.25 $0.33 -$0.08
08/06/2020 Q2 -- -- -$0.44 -$0.05 -$0.39
05/08/2020 Q1 -- -- -$0.63 $0.39 -$1.02
03/02/2020 Q4 -- -- $0.46 $0.75 -$0.29
11/07/2019 Q3 -- -- $0.38 $0.50 -$0.12
08/02/2019 Q2 -- -- $0.16 $0.62 -$0.46
05/03/2019 Q1 -- -- $0.17 $0.39 -$0.22
03/01/2019 Q4 -- -- $0.01 $0.54 -$0.53
11/08/2018 Q3 -- -- $0.13 $0.46 -$0.33
08/07/2018 Q2 -- -- -$4.98 -- --
05/06/2018 Q1 -- -- $0.35 -- --
03/01/2018 Q4 -- -- -$2.95 -- --
11/03/2017 Q3 -- -- $0.39 -- --
08/09/2017 Q2 -- -- -$4.58 -- --
05/09/2017 Q1 -- -- $0.26 -- --
02/17/2017 Q4 -- -- $0.46 -- --
11/04/2016 Q3 -- -- $0.39 -- --
08/05/2016 Q2 -- -- $0.44 -- --
05/06/2016 Q1 -- -- $0.70 -- --
02/12/2016 Q4 -- -- $0.41 -- --
10/28/2015 Q3 -- -- $0.59 -- --
07/30/2015 Q2 -- -- $0.31 -- --

Dentsply Sirona Earnings Questions

  • How Much did Dentsply Sirona Generate in Revenue Last Quarter?

    Dentsply Sirona reported $879M worth of top line sales in its most recent quarter.

  • Did Dentsply Sirona Beat Earnings Last Quarter?

    Dentsply Sirona announced earnings per share of $0.10 which represents a miss of analyst forecast a $0.30 per share.

  • Is Dentsply Sirona Profitable?

    Dentsply Sirona reported $466M that represents $2.33 per share over the last quarter.

  • What is the Analyst Consensus for Dentsply Sirona EPS Next Year?

    Dentsply Sirona's earnings are forecast to grow from -$4.48 per share to $1.84 per share next year representing an increase of --.

  • When is Dentsply Sirona's Earnings Date?

    Dentsply Sirona's next earnings date is July 31, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock